The chemical class termed Blood Group Lewis x Activators refers to a collection of compounds that are designed to influence or modulate the expression, synthesis, or display of the Lewis x (Le^x) antigen structure on cells and proteins. The Lewis x structure, which is characterized as Galβ1-4(Fucα1-3)GlcNAc, is an essential component of certain glycolipids and glycoproteins found on the surfaces of various cells. The activators pertinent to this class play a pivotal role in the biochemical pathways that regulate this specific glycosylation.
Molecular synthesis, transportation, and presentation of Lewis x structures require a tightly coordinated system of enzymes, substrates, and cofactors. Blood Group Lewis x Activators often function by either directly providing necessary chemical building blocks or by modulating the activity of key enzymes that produce the Le^x structure. For instance, GDP-Fucose and UDP-Galactose are essential substrates for the glycosyltransferases involved in the formation of Le^x structures. Meanwhile, other chemicals in this class might interact with the cellular machinery responsible for glycan processing, either promoting or inhibiting specific steps in the complex assembly of the Lewis x structures. In summary, Blood Group Lewis x Activators constitute a diverse class of compounds that are integral to the molecular landscape governing the biosynthesis and display of the Lewis x antigen on cell surfaces.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Brefeldin A | 20350-15-6 | sc-200861C sc-200861 sc-200861A sc-200861B | 1 mg 5 mg 25 mg 100 mg | $31.00 $53.00 $124.00 $374.00 | 25 | |
A fungal metabolite that interferes with protein transport from the endoplasmic reticulum to the Golgi apparatus, affecting glycosylation patterns. | ||||||
N-Acetyl-D-galactosamine | 1811-31-0 | sc-221979 sc-221979A sc-221979C sc-221979B sc-221979D | 10 mg 100 mg 1 g 5 g 50 g | $51.00 $77.00 $267.00 $1040.00 $1326.00 | ||
When introduced to cells, can potentially increase the O-GalNAc type glycosylation. | ||||||